Document is current
Any future updates will be listed below
-
Authors
Iba, Toshiaki https://orcid.org/0000-0002-0255-4088
Helms, Julie https://orcid.org/0000-0003-0895-6800
Connors, Jean Marie https://orcid.org/0000-0001-6445-582X
Levy, Jerrold H. https://orcid.org/0000-0003-3766-4962
-
Funding
Funding for this research was provided by:
Grant-in-Aid for Special Research in Subsidies for ordinary expenses of private schools from The Promotion and Mutual Aid Corporation for Private Schools of Japan
- License Information
-
More Information
Article History
Received: 5 January 2023
Accepted: 18 May 2023
First Online: 23 May 2023
Declarations
:
: Not applicable.
: Not applicable.
: TI has participated in advisory boards of Japan Blood Products Organization, Toray Medical, and Asahi Kasei Pharmaceuticals and received a research grant from JIMRO. JH has received honoraria from Diagnostica Stago, Pfizer PFE France and Sanofi Aventis France, MSD, Shionogi, and Inotrem. JMC has participated in scientific advisory boards and consulting from Abbott, Anthos, Alnylam, Bristol Myers Squibb, Five Prime Therapeutics, Pfizer, Takeda, and research funding from CSL Behring. JHL serves on the Steering Committees for Merck, Octapharma, and Werfen.
